About
No bio available.
Skills & Expertise
No skills added yet.
Research Interests
No research interests added yet.
Connect With Me
Publications (1)
Fixed-treatment duration glofitamab and treat-to-progression epcoritamab are approved in the US for diffuse large B-cell lymphoma (DLBCL) after ≥2 prior therapies. An economic model was developed to e...
dd